<DOC>
	<DOCNO>NCT00004173</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness oxaliplatin paclitaxel treat patient metastatic unresectable cancer .</brief_summary>
	<brief_title>Oxaliplatin Paclitaxel Treating Patients With Metastatic Unresectable Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose oxaliplatin paclitaxel patient metastatic unresectable cancer . - Determine qualitative quantitative toxicity regimen patient . - Determine therapeutic response regimen patient . - Determine relationship pharmacokinetics regimen toxicity response patient . - Determine effect oxaliplatin peripheral blood cell correlate pharmacokinetics , toxicity , response patient . OUTLINE : This dose escalation study . Patients receive oxaliplatin IV 2 hour follow paclitaxel IV 1 hour weekly 4 week . Treatment repeat every 6 week absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos oxaliplatin paclitaxel maximum tolerate dose ( MTD ) determine . The MTD define dose 1 6 patient experience dose limit toxicity . PROJECTED ACCRUAL : Approximately 20 patient accrue study within 12-18 month .</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven metastatic unresectable malignancy standard curative palliative measure exist longer effective No known brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Karnofsky 50100 % Life expectancy : Not specify Hematopoietic : WBC least 3000/mm^3 Absolute neutrophil count least 1500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin normal SGOT/SGPT great 2.5 time upper limit normal Renal : Creatinine normal OR Creatinine clearance least 60 mL/min Cardiovascular : No symptomatic congestive heart failure No unstable angina pectoris No cardiac arrhythmia Other : No neuropathy Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No allergy platinum compound antiemetic No uncontrolled concurrent illness No active infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No 2 prior chemotherapy regimens No prior oxaliplatin paclitaxel At least 4 week since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy No prior radiotherapy 25 % bone marrow Surgery : Not specify Other : No concurrent investigational agent No concurrent antiretroviral therapy HIV ( HAART )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2003</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>